Rv1630 - c.265C>T
Drug resistance types
2 Sensitive
0 RR-TB
4 HR-TB
0 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
9 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.6.1.1 | 2 |
| La1.2;La1.8.1 | 1 |
| M.canetti | 1 |
| La1;lineage4.9 | 1 |
| lineage4.9 | 4 |
| La3;M.canetti | 1 |
| La3;lineage4.2;lineage4.6.4;lineage4.9;lineage6.3 | 1 |
| La3;lineage4.9 | 2 |
| La3;M.canetti;lineage4.2;lineage4.6.4;lineage4.9;lineage6.3 | 1 |
| La3;lineage4.3.4 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 15 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Variant Proportion
Hover over a Country 0–0.1
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 |
|---|---|---|---|
| ERR987765 | Sensitive | lineage4.6.1.1 | None |
| SRR7240033 | Other | La1.2;La1.8.1 | None |
| ERR266124 | Other | M.canetti | None |
| ERR4769497 | Other | La1;lineage4.9 | None |
| ERR4818929 | HR-TB | lineage4.9 | None |
| ERR266125 | Other | La3;M.canetti | None |
| ERR4820773 | HR-TB | lineage4.9 | None |
| ERR5311091 | Other | La3;lineage4.2;lineage4.6.4;lineage4.9;lineage6.3 | None |
| ERR161037 | Other | lineage4.9 | None |
| SRR28119827 | Other | La3;lineage4.9 | None |
| ERR181744 | HR-TB | La3;lineage4.9 | None |
| ERR1199132 | Sensitive | lineage4.6.1.1 | None |
| ERR212123 | Other | lineage4.9 | None |
| SRR6046482 | Other | La3;M.canetti;lineage4.2;lineage4.6.4;lineage4.9;lineage6.3 | None |
| ERR161039 | HR-TB | La3;lineage4.3.4 | None |
